A carregar...

Adipose cells promote resistance of breast cancer cells to trastuzumab-mediated antibody-dependent cellular cytotoxicity

INTRODUCTION: Trastuzumab has been used in the treatment of human epidermal growth factor receptor 2 (HER2)-expressing breast cancer, but its efficacy is limited by de novo or acquired resistance. Although many mechanisms have been proposed to explain resistance to trastuzumab, little is known conce...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer Res
Main Authors: Duong, Minh Ngoc, Cleret, Aurore, Matera, Eva-Laure, Chettab, Kamel, Mathé, Doriane, Valsesia-Wittmann, Sandrine, Clémenceau, Béatrice, Dumontet, Charles
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4482271/
https://ncbi.nlm.nih.gov/pubmed/25908175
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-015-0569-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!